Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10000454HBVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS10024515HBVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS10030586HBVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS10053076HBVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS30087144HIVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS30065198HIVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS30065199HIVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS20019502HPVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS20045985HPVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TVIS20060442HPVENSG00000137252.10protein_codingHCRTR2NoNo3062O43614
S4X0W3
TCGA Plot Options
Drug Information
GeneHCRTR2
DrugBank IDDB09034
Drug NameSuvorexant
Target IDBE0005865
UniProt IDO43614
Regulation Typeantagonist
PubMed IDs23702225
CitationsPalasz A, Lapray D, Peyron C, Rojczyk-Golebiewska E, Skowronek R, Markowski G, Czajkowska B, Krzystanek M, Wiaderkiewicz R: Dual orexin receptor antagonists - promising agents in the treatment of sleep disorders. Int J Neuropsychopharmacol. 2014 Jan;17(1):157-68. doi: 10.1017/S1461145713000552. Epub 2013 May 23.
GroupsApproved; Investigational
Direct ClassificationN,N-dialkyl-m-toluamides
SMILES[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2
Pathways
PharmGKB
ChEMBLCHEMBL1083659